Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Entertainment Insider.
'Let’s Walk' with Halli: A Podcast Designed to Spark Creativity—One Conversation at a Time
EIN Presswire
·
June 24, 2025
REYKJAVíK, ICELAND, June 24, 2025 /EINPresswire.com/ -- What happens when you take creativity outside, strip away the scripts, and let the world set the pace? You get Let’s Walk—a new biweekly podcast from Icelandic designer and entrepreneur...
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
GlobeNewswire, Inc.
·
July 1, 2025
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
GlobeNewswire, Inc.
·
June 26, 2025
REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders...
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
GlobeNewswire, Inc.
·
June 25, 2025
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
June 23, 2025
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered...
Lucinity Achieves Microsoft Certified Software for Financial AI
GlobeNewswire, Inc.
·
July 8, 2025
REYKJAVIK, Iceland, July 08, 2025 (GLOBE NEWSWIRE) -- Lucinity, a leading provider of anti-financial crime software, announced today that its platform is now officially recognized as Microsoft Certified Software for Financial AI. This...
Whole Health at VA Pittsburgh
U.S. Department of Veterans Affairs
·
August 11, 2025
Enter through the front doors of the H. John Heinz III campus of the VA Pittsburgh Healthcare System on any given day and you might see Veterans doing yoga, tai chi, weightlifting and any number of other physical activities. What you’re really...
QFSCOIN Launches the Most Profitable Platform for Yielding Crypto in 2025, Designed for Global Investors to Earn BTC, LTC, and DOGE coin
GlobeNewswire, Inc.
·
July 23, 2025
New York City, NY, July 23, 2025 (GLOBE NEWSWIRE) -- Dogecoin (DOGE) is making headlines again, this time, not just for memes and social media hype. Recent on-chain data reveals that whales, the largest investors in the market, are quietly...
Century Aluminum Company Reports Second Quarter 2025 Results
GlobeNewswire, Inc.
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its second quarter 2025 results. Second Quarter 2025 Financial Results $MM (except shipments and per share data) Q2 2025 Q1 2025 Aluminum shipments...
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
GlobeNewswire, Inc.
·
June 6, 2025
REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Citing Benefits of 232 Tariffs, Century Aluminum Announces Restart to Bring Mt. Holly SC Plant to Full Production, Increasing U.S. Aluminum Production by 10%
GlobeNewswire, Inc.
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) has announced plans to restart over 50,000MT of idled production at its Mt. Holly, SC smelter. Century will invest approximately $50 million in the effort, create...
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
GlobeNewswire, Inc.
·
June 2, 2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
XRP is attracting much attention, and LET Mining has launched a new cloud mining service program to obtain daily income
GlobeNewswire, Inc.
·
July 14, 2025
New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- Remittix (RTX) has attracted much attention from many investors, especially in the cross-border payment market. It is hailed as the most worthwhile cryptocurrency to buy at present. In response,...
AIXA Miner Launches Free-to-Start Cloud Mining Platform to Simplify Passive Crypto Income in 2025
GlobeNewswire, Inc.
·
July 9, 2025
New York City, NY, July 09, 2025 (GLOBE NEWSWIRE) -- As cryptocurrency adoption continues to surge, AIXA Miner is leading the next generation of simplified crypto earning with the launch of its free-to-start cloud mining platform. Designed for...
Turkish Repkon Partners with Norway's Nammo to Launch Artillery Facility
MENAFN
·
July 6, 2025
(MENAFN) Repkon, a leading Turkish defense company, is set to build a state-of-the-art 155-millimeter artillery ammunition filling facility, as part of a strategic agreement with Norwegian defense contractor Nammo. This initiative aims to bolster...
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
GlobeNewswire, Inc.
·
June 5, 2025
HYDERABAD, India and REYKJAVIK, Iceland, June 05, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr....
Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada
GlobeNewswire, Inc.
·
May 9, 2025
REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA...
Oculis Upsized Loan Facility to Access up to CHF 100 million
GlobeNewswire, Inc.
·
August 1, 2025
ZUG, Switzerland, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025
GlobeNewswire, Inc.
·
May 7, 2025
REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the...
Why High-Net-Worth Investors Are Turning to BTC Miner for Daily Crypto Returns Amid Market Turbulence
GlobeNewswire, Inc.
·
July 4, 2025
Chicago, Illinois, July 03, 2025 (GLOBE NEWSWIRE) -- Introducing BTC Miner — the cloud mining solution designed not for traders, but for wealth builders. For family offices, crypto funds, and large-scale investors seeking dependable yield in a...